Neuropace, Inc. NPCE Balance Sheet Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| $15.63M-42.4% | $21.81M+61.0% | $20.77M+33.7% | $22.98M+77.2% | $27.14M+107% | ||
| $39.2M-0.1% | $39.37M+0.1% | $39.37M-4.9% | $39.28M-8.0% | $39.24M-14.6% | ||
| $57.96M+13.5% | $58.61M+23.9% | $56.78M+21.5% | $53.4M+14.9% | $51.09M+10.8% | ||
| $68.07M+35.0% | $64.96M+34.6% | $61.44M+33.3% | $55.39M+26.6% | $50.41M+18.9% | ||
| $86.98M-10.8% | $94.07M+15.7% | $95.33M+15.4% | $93.74M+16.8% | $97.48M+15.7% | ||
| $1.28M+10.6% | $1.13M+6.9% | $1.11M+6.4% | $1.16M+15.8% | $1.16M+10.7% | ||
| $98.9M-10.3% | $105.57M+11.5% | $107.26M+11.4% | $106.11M+12.4% | $110.21M+11.5% | ||
| $16.04M+40.1% | $15.57M+45.9% | $16.31M+62.3% | $13.88M+52.6% | $11.45M+32.9% | ||
| $126K-81.5% | $141K-74.6% | $649K-13.4% | $696K— | $680K— | ||
| $16.17M+9.9% | $17.81M+17.5% | $19.61M+32.7% | $17.14M+36.2% | $14.71M+12.2% | ||
| $59.02M-1.3% | $58.88M-1.1% | $58.75M-0.9% | $58.62M-0.7% | $59.79M+3.0% | ||
| $0— | $0— | $0— | $0— | $0— | ||
| 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | 200M0.0% | ||
| -$559.1M-4.0% | -$552.42M-4.0% | -$549.69M-4.6% | -$546.19M-5.0% | -$537.54M-4.8% | ||
| $14.45M-40.4% | $19.03M+138% | $18.52M+88.5% | $19.44M+96.6% | $24.27M+69.2% | ||
| $98.9M-10.3% | $105.57M+11.5% | $107.26M+11.4% | $106.11M+12.4% | $110.21M+11.5% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Neuropace, Inc.'s total assets?
- Neuropace, Inc. (NPCE) holds $98.9M in total assets, down 10.3% year over year.
- How much debt does Neuropace, Inc. have?
- Neuropace, Inc. carries $70.5M in total debt against $14.5M of shareholders' equity, a debt-to-equity ratio of 4.87.
- How much cash does Neuropace, Inc. have?
- Neuropace, Inc. holds $15.6M in cash and equivalents.
- Can Neuropace, Inc. cover its short-term obligations?
- Its current ratio is 5.38 — current assets exceed current liabilities.
- Where does Neuropace, Inc.'s balance sheet data come from?
- Every line is extracted from Neuropace, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
